COVID-19 vaccine has shown positive results in the initial trial. The vaccine candidate is safe and prompts protective immune response, according to a report in The Lancet.British-Swedish pharmaceutical company AstraZeneca has partnered with Serum Institute of India (SII) to produce the vaccine in India and middle and low-income countries.
The Pune-based firm already sought permission from Drug Controller General of India (DCGI) to start the advanced trial in India.